Cancer News and Research

Latest Cancer News and Research

AstraZeneca and Pfizer support Cancer Research UK in £5.5m Stratified Medicine programme

CANCER RESEARCH UK will be supported by AstraZeneca and Pfizer in a multimillion pound initiative to examine how genetic tests to improve cancer diagnosis can be best rolled out across the NHS.

1 Feb 2011

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

1 Feb 2011

American Cancer Society reports racial disparity continues to increase death rate for some cancers

While the overall death rate for cancer continues to drop among African Americans, the group continues to have higher death rates and shorter survival of any racial and ethnic group in the U.S. for most cancers. The findings come from Cancer Facts & Figures for African Americans 2011-2012, the latest edition of a report produced every two years by the American Cancer Society.

1 Feb 2011

Oncology experts to discuss latest developments in head and neck cancers

The European Society for Therapeutic Radiology and Oncology (ESTRO), the European Head and Neck Society (EHNS), and the European Society for Medical Oncology (ESMO) in collaboration with other European partners, have the pleasure of inviting you to report on the 3rd International Conference on innovative approaches In Head and Neck Oncology that will be held in Barcelona (Spain) on the 24th -26th February 2011.

1 Feb 2011

Genzyme, Sanofi-Aventis enter confidentiality agreement

Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.

1 Feb 2011

ISCO, Springer to collaborate to publish Cellular Oncology journal

Springer and the International Society of Cellular Oncology will collaborate to publish Cellular Oncology starting this year. Cellular Oncology is the official journal of ISCO and publishes original papers and reviews on the latest advances in cancer research. It was previously published by IOS Press.

1 Feb 2011

Fox Chase announces posting of clinical outcomes data to its website for patient use

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced the posting of clinical outcomes data to its website as a tool to assist newly-diagnosed patients in deciding where to seek cancer care.

1 Feb 2011

Painless, noninvasive biopsies with smart laser technology

Biopsies in the future may be painless and noninvasive, thanks to smart laser technology being developed at Michigan State University.

1 Feb 2011

FDA approves 'Cornell Dots' for first clinical trial in humans to diagnose cancer

"Cornell Dots" - brightly glowing nanoparticles - may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administration has approved the first clinical trial in humans of the new technology.

1 Feb 2011

MRI screening for breast cancer delivers fewer false-positive results over time

MRI screening for breast cancer delivers consistent rates of cancer detection and fewer false-positive results over time, according to a new study published online and in the April print edition of Radiology.

1 Feb 2011

Roundup: Tenn. community health centers feel budget pinch; Minn. faces struggles with costs of inmate care

Originally created to care for destitute urban dwellers or dirt-poor sharecroppers, health centers today serve a much wider segment of America. A prolonged recession and a shortage of primary care physicians have expanded their patient base. Going forward, they are expected to meet the needs of millions more Americans. But getting there could be a challenge.

1 Feb 2011

Novel personalized therapy could treat metastatic melanoma and metastatic synovial cell sarcoma

Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.

1 Feb 2011

Duke, LifePoint enter joint venture to improve healthcare delivery for North Carolina community hospitals

Duke University Health System, Inc. and LifePoint Hospitals® have formed DLP Healthcare, LLC (Duke/LifePoint), a joint venture designed to strengthen and improve healthcare delivery throughout North Carolina and the surrounding regions by creating flexible affiliation options for community hospitals.

1 Feb 2011

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.

1 Feb 2011

Yale University scientists synthesize lomaiviticin that appears to destroy cancer stem cells

A team of Yale University scientists has synthesized for the first time a chemical compound called lomaiviticin aglycon, leading to the development of a new class of molecules that appear to target and destroy cancer stem cells.

1 Feb 2011

Johns Hopkins-led safety checklist program appears to reduce hospital deaths by 10%

A Johns Hopkins-led safety checklist program that virtually eliminated bloodstream infections in hospital intensive-care units throughout Michigan appears to have also reduced deaths by 10 percent, a new study suggests.

1 Feb 2011

Scientists devise safer way to create iPS cells

Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.

1 Feb 2011

CINJ Foundation, Panera Bread enter joint venture to fight against cancer

Panera Bread has expanded its contributions to the fight against cancer by selecting the Cancer Institute of New Jersey Foundation as its Community Breadbox Partner for 2011.

1 Feb 2011

Research on triple negative disease can benefit patients with breat cancer

Research to develop more effective treatments for triple negative breast cancer -- a difficult disease to cure -- could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.

1 Feb 2011

“Enjoy your food but eat less”: Latest Dietary guidelines

New federal dietary guidelines, released Monday by the U.S. Department of Agriculture and the Department of Health and Human Services lays down some new rules in healthy eating that include consuming less empty calories, less salt and at least half a plate full of fruits and vegetables a day.

1 Feb 2011

Cancer News and Research

Latest Cancer News and Research

AstraZeneca and Pfizer support Cancer Research UK in £5.5m Stratified Medicine programme

Octreotide inhibits HepG2 proliferation, study confirms

American Cancer Society reports racial disparity continues to increase death rate for some cancers

Oncology experts to discuss latest developments in head and neck cancers

Genzyme, Sanofi-Aventis enter confidentiality agreement

ISCO, Springer to collaborate to publish Cellular Oncology journal

Fox Chase announces posting of clinical outcomes data to its website for patient use

Painless, noninvasive biopsies with smart laser technology

FDA approves 'Cornell Dots' for first clinical trial in humans to diagnose cancer

MRI screening for breast cancer delivers fewer false-positive results over time

Roundup: Tenn. community health centers feel budget pinch; Minn. faces struggles with costs of inmate care

Novel personalized therapy could treat metastatic melanoma and metastatic synovial cell sarcoma

Duke, LifePoint enter joint venture to improve healthcare delivery for North Carolina community hospitals

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Yale University scientists synthesize lomaiviticin that appears to destroy cancer stem cells

Johns Hopkins-led safety checklist program appears to reduce hospital deaths by 10%

Scientists devise safer way to create iPS cells

CINJ Foundation, Panera Bread enter joint venture to fight against cancer

Research on triple negative disease can benefit patients with breat cancer

“Enjoy your food but eat less”: Latest Dietary guidelines

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in